MITIGO

Piramal Critical Care, Inc.🇺🇸 United States

FDA Page

Effective Date: Feb 19, 2026
Approval ID: 728f3d83-9a63-0c1f-e053-2a91aa0ac7db
Products: 2 registered
Version: 12

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use MITIGO® safely and effectively. See full prescribing information for MITIGO . MITIGO (morphine sulfate injection), Preservative-free, injectable solution, for intrathecal or epidural infusion, using a continuous microinfusion device, CII Initial U.S. Approval: 1941

Quick Stats

Total Products2

Labelers2

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.